Bo Chen
12 Papers
1 Citations
Bo Chen is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 7 publications.
Chat about Author
Papers
A Novel Nomogram Model to Identify Candidates and Predict the Possibility of Benefit From Primary Tumor Resection Among Female Patients With Metastatic Infiltrating Duct Carcinoma of the Breast: A Large Cohort Study
TL;DR: It is suggested that primary tumor surgery improved the prognosis of female patients with stage IV BIDC and a nomogram to quantify the probability of surgical benefit to help identify surgical candidates clinically was developed.
Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation
Fei Qi,Wenyuan Zhou,Yuan Xie,Yan Sun,Meng Wu,Y Chai,Bo Chen,Ningjing Lin,Weiping Liu,Ning Ding,Yexiong Li,Mei Dong,Yuqin Song,Jun Zhu +13 more
TL;DR: In this article , the authors evaluated the association between induction chemotherapy (CT) response and survivals and explored an induction CT response-adapted treatment strategy for localized extranodal NK/T-cell lymphoma (NKTCL) receiving first-line sequential CT and radiation (RT).
Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: a propensity score-matched analysis based on phase II study.
Liu-Hua Long,Bo Chen,Hongzhi Wang,Yuting Zhao,Fan Wu,Liping Wang,Weiqi Rong,Jianxiong Wu,Yexiong Li,Weihu Wang +9 more
TL;DR: In this paper , the authors evaluated the postoperative radiotherapy (PORT) effects on hepatocellular carcinoma (HCC) prognosis and recurrence in patients who underwent narrow-margin hepatectomy (NH).
4
The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study
Liping Wang,Yunhe Liu,Weiqi Rong,Fan Wu,Weibo Yu,Kan Liu,Shengtao Lin,Yiling Zheng,Kai Zhang,Tana Siqin,Changcheng Tao,Mei Liu,Bo Chen,Qinfu Feng,Jianxiong Wu +14 more
TL;DR: Subgroup analysis revealed that IOERT was more beneficial for postoperative survival of HCC patients with MVI, and Statistically better RFS rate was observed in the IOERT group compared to the control group.
3
Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial
Changcheng Tao,Fan Wu,Hongwei Wang,Liping Wang,Yu Liu,Anke Wu,Linlin Zheng,Yaru Wang,Bo Chen,Weiqi Rong,Jianxiong Wu +10 more
TL;DR: In this paper , the authors used propensity-score analysis and Cox proportional-hazards regression models to assess the sensitivity to unmeasured confounding in centrally located hepatocellular carcinoma (HCC).
1